<DOC>
	<DOCNO>NCT00640952</DOCNO>
	<brief_summary>The purpose study determine many patient Parkinson 's disease compulsive behavior , type behavior . This study also determine acamprosate use treat compulsive behavior Parkinson 's disease patient .</brief_summary>
	<brief_title>Acamprosate Treatment Compulsive Behaviors Craving Parkinson 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Compulsive Behavior</mesh_term>
	<mesh_term>Obsessive-Compulsive Disorder</mesh_term>
	<mesh_term>Acamprosate</mesh_term>
	<criteria>1 . Idiopathic Parkinson 's disease 2 . Active dopaminergic therapy stable dose one month ( levodopa dopamine agonist ) 3 . Able willing complete Rating Scales 4 . Presence one compulsive behavior base response Rating Scales ( define &gt; 5 SOGS ; &gt; 17 YBOCSSV YBOCSCUV ; &gt; 1.7 SCS woman &gt; 2.1 SCS men ; &gt; 15 YBOCSBE , &gt; 5.5 CQ ) . 5 . Written inform consent Inclusion criterion ( control ) : 1 . No significant psychiatric disease 2 . Able willing complete Rating Scales 3 . Written inform consent 1 . No anticipated need adjustment medication Parkinson 's disease 2 . Current participation another clinical study 3 . History unstable psychiatric disease ( determine Principal Investigator ) 4 . Women childbearing age use appropriate contraceptive method ( oral contraceptive , condom , surgery )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Parkinson 's disease</keyword>
	<keyword>impulse control behavior</keyword>
	<keyword>dopa-dysregulation</keyword>
</DOC>